Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03595124 · OUTCOME

Pharmacokinetics (PK) Parameters of Axitinib

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) · Source last updated 2026-08-28

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 12 weeks from study entry

What was measured

PKs will be evaluated at day 1 of cycles 1, 2, and 3.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
PKs will be evaluated at day 1 of cycles 1, 2, and 3.
reporting Status
NOT_POSTED
time Frame
Up to 12 weeks from study entry
title
Pharmacokinetics (PK) Parameters of Axitinib
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice